pyrazolanthrone has been researched along with lactoferrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banno, Y; Kato, Y; Kawaguchi, M; Nozawa, Y; Sakai, T | 1 |
| Kato, H; Morishita, S; Murakoshi, M; Nishino, H; Ono, T; Saito, K; Sugiyama, K; Tomita, K | 1 |
2 other study(ies) available for pyrazolanthrone and lactoferrin
| Article | Year |
|---|---|
Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells.
Topics: Animals; Anthracenes; Apoptosis; Cattle; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Lactoferrin; Mouth Neoplasms; Pepsin A | 2005 |
Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Topics: Animals; Anthracenes; Apoptosis; Benzimidazoles; Cattle; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Lactoferrin; Lipid Metabolism; Lipotropic Agents; Liver; MAP Kinase Signaling System; Non-alcoholic Fatty Liver Disease; Peptide Fragments; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinoxalines | 2015 |